Human platelets circulating in mice: Applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders

Journal of Thrombosis and Haemostasis

Volumn 5, Issue SUPPL. 1, 2007, Pages 305-309

  Newman, Peter J ^a   Aster, R ^a   Boylan, B ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; B LYMPHOCYTE RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN VI; T LYMPHOCYTE RECEPTOR;

ANTIBODY PRODUCTION; ANTICOAGULANT THERAPY; AUTOIMMUNE THROMBOCYTOPENIA; DRUG EFFICACY; DRUG TARGETING; HUMAN; IN VIVO STUDY; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCID MOUSE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; THROMBOCYTE PRESERVATION; THROMBOCYTE RICH PLASMA;

EID: 34250714506     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02466.x     Document Type: Review

References (22)

1. Ueda T, Yoshino H, Kobayashi K, Kawahata M, Ebihara Y, Ito M, Asano S, Nakahata T, Tsuji K. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice. Stem Cells 2000; 18: 204-13.
2. Ueda T, Yoshida M, Yoshino H, Kobayashi K, Kawahata M, Ebihara Y, Ito M, Asano S, Nakahata T, Tsuji K. Hematopoietic capability of CD34+ cord blood cells: A comparison with CD34+ adult bone marrow cells. Int J Hematol 2001; 73: 457-62.
3. Perez LE, Rinder HM, Wang C, Tracey JB, Maun N, Krause DS. Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production. Blood 2001; 97: 1635-43.
4. Boylan B, Berndt MC, Kahn ML, Newman PJ. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood 2006; 108: 908-14.
5. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180-91.
6. Koyanagi Y, Tanaka Y, Kira J, Ito M, Hioki K, Misawa N, Kawano Y, Yamasaki K, Tanaka R, Suzuki Y, Ueyama Y, Terada E, Tanaka T, Miyasaka M, Kobayashi T, Kumazawa Y, Yamamoto N. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J Virol 1997; 71: 2417-24.
7. Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, Mitsui T, Manabe A, Tanaka R, Kobayashi K, Ito M, Yasukawa K, Nakahata T. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/ Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 2000; 105: 1013-21.
8. Bruno S, Gunetti M, Gammaitoni L, Perissinotto E, Caione L, Sanavio F, Fagioli F, Aglietta M, Piacibello W. Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells. Stem Cells 2004; 22: 135-43.
9. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 2000; 37: 239-48.
10. Boylan B, Chen H, Rathore V, Paddock C, Salacz M, Friedman KD, Curtis BR, Stapleton MA, Newman DK, Kahn ML, Newman PJ. Anti-GPVI-associated ITP: An acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface. Blood 2004; 104: 1350-5.
11. Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 2001; 193: 459-69.
12. Bergmeier W, Rabie T, Strehl A, Piffath CL, Prostredna M, Wagner DD, Nieswandt B. GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thromb Haemost 2004; 91: 951-8.
13. Newman PJ, McFarland JG, Aster RH. The alloimmune thrombocytopenias. In: Loscalzo J and Schafer AI, eds. Thrombosis and Hemorrhage, 3rd edn. Philadelphia: Lippincott and Williams, 2003: 441-56.
14. Aster RH. Drug-induced immune thrombocytopenia: An overview of pathogenesis. Semin Hematol 1999; 36: 2-6.
15. Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK. Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 2004; 104: 3611-7.
16. Chen H, Locke D, Liu Y, Liu C, Kahn ML. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem 2002; 277: 3011-9.
17. Becker GA, Tuccelli M, Kunicki T, Chalos MK, Aster RH. Studies of platelet concentrates stored at 22 °C and 4 °C. Transfusion 1973; 13: 61-8.
18. Aster RH. Platelet survival as a measure of the effectiveness of stored platelets. Vox Sang 1981; 40(Suppl. 1): 55-61.
19. Gottschall JL, Rzad L, Aster RH. Studies of the minimum temperature at which human platelets can be stored with full maintenance of viability. Transfusion 1986; 26: 460-2.
20. Menitove JE, Kagen LR, Aster RH. Recovery and survival in vivo of platelet concentrates prepared with prostaglandin E1. Transfusion 1988; 28: 56-8.
21. Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, Von Andrian UH, Wagner DD, Stossel TP, Hartwig JH. The clearance mechanism of chilled blood platelets. Cell 2003; 112: 87-97.
22. Wilcox DA, Olsen JC, Ishizawa L, Griffith M, White GC. Integrin αIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells. Proc Natl Acad Sci USA 1999; 96: 9654-9.